Literature DB >> 32251616

Comparison of Characteristics of Patients with West Nile Virus or St. Louis Encephalitis Virus Neuroinvasive Disease During Concurrent Outbreaks, Maricopa County, Arizona, 2015.

Heather Venkat1,2,3, Elisabeth Krow-Lucal3,4, Melissa Kretschmer2, Tammy Sylvester2, Craig Levy2, Laura Adams1,5, Kathryn Fitzpatrick6, Janeen Laven4, Olga Kosoy4, Rebecca Sunenshine2,5, Kirk Smith7, John Townsend7, Jennifer Chevinsky8, Morgan Hennessey3,4, Jefferson Jones1,2,3, Ken Komatsu1, Marc Fischer4, Susan Hills4.   

Abstract

West Nile virus (WNV) and St. Louis encephalitis virus (SLEV) are closely related mosquito-borne flaviviruses that can cause neuroinvasive disease. No concurrent WNV and SLEV disease outbreaks have previously been identified. When concurrent outbreaks occurred in 2015 in Maricopa County, Arizona, we collected data to describe the epidemiology, and to compare features of patients with WNV and SLEV neuroinvasive disease. We performed enhanced case finding, and gathered information from medical records and patient interviews. A case was defined as a clinically compatible illness and laboratory evidence of WNV, SLEV, or unspecified flavivirus infection in a person residing in Maricopa County in 2015. We compared demographic and clinical features of WNV and SLEV neuroinvasive cases; for this analysis, a case was defined as physician-documented encephalitis or meningitis and a white blood cell count >5 cells/mm3 in cerebrospinal fluid. In total, we identified 82 cases, including 39 WNV, 21 SLEV, and 22 unspecified flavivirus cases. The comparative analysis included 21 WNV and 14 SLEV neuroinvasive cases. Among neuroinvasive cases, the median age of patients with SLEV (63 years) was higher than WNV (52 years). Patients had similar symptoms; rash was identified more frequently in WNV (33%) neuroinvasive cases than in SLEV (7%) cases, but this difference was not statistically significant (p = 0.11). In summary, during the first known concurrent WNV and SLEV disease outbreaks, no specific clinical features were identified that could differentiate between WNV and SLEV neuroinvasive cases. Health care providers should consider both infections in patients with aseptic meningitis or encephalitis.

Entities:  

Keywords:  St. Louis encephalitis virus; West Nile virus; encephalitis; neuroinvasive; outbreak

Mesh:

Year:  2020        PMID: 32251616      PMCID: PMC7909845          DOI: 10.1089/vbz.2019.2572

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  19 in total

1.  Serum dilution neutralization test for California group virus identification and serology.

Authors:  H S Lindsey; C H Calisher; J H Mathews
Journal:  J Clin Microbiol       Date:  1976-12       Impact factor: 5.948

2.  Persistent West Nile virus transmission and the apparent displacement St. Louis encephalitis virus in southeastern California, 2003-2006.

Authors:  William K Reisen; Hugh D Lothrop; Sarah S Wheeler; Marc Kennsington; Arturo Gutierrez; Ying Fang; Sandra Garcia; Branka Lothrop
Journal:  J Med Entomol       Date:  2008-05       Impact factor: 2.278

3.  Clinical and laboratory features of epidemic St. Louis encephalitis.

Authors:  P M Southern; J W Smith; J P Luby; J A Barnett; J P Sanford
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  The epidemiology of St. Louis encephalitis in Dallas, Texas, 1966.

Authors:  C C Hopkins; F B Hollinger; R F Johnson; H J Dewlett; V F Newhouse; R W Chamberlain
Journal:  Am J Epidemiol       Date:  1975-07       Impact factor: 4.897

6.  Medical risk factors for severe West Nile Virus disease, United States, 2008-2010.

Authors:  Nicole P Lindsey; J Erin Staples; Jennifer A Lehman; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

7.  West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003.

Authors:  Amy V Bode; James J Sejvar; W John Pape; Grant L Campbell; Anthony A Marfin
Journal:  Clin Infect Dis       Date:  2006-03-30       Impact factor: 9.079

8.  Lack of evidence of increased West Nile virus disease severity in the United States in 2012.

Authors:  Nicole P Lindsey; J Erin Staples; Mark J Delorey; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

Review 9.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

10.  St. Louis Encephalitis Virus Disease in the United States, 2003-2017.

Authors:  Emily J Curren; Nicole P Lindsey; Marc Fischer; Susan L Hills
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.